Literature DB >> 35767192

Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma.

Xin Li1, Xinyu Su2, Chen Yan1, Yuanyuan Ma1, Heng Li1, Jianhong Xia1, Hongliang Li1, Qian Jiang1, Liqing Zhou3, Zhengyun Zou4,5,6.   

Abstract

Vascular endothelial growth factor (VEGF) is related to the radiation resistance of tumors, resulting in the failure of tumor radiotherapy. The purpose of this study was to discuss the role of VEGF in radiotherapy resistance of esophageal squamous cell carcinoma (ESCC). We used the VEGF kit by ELISA to detect the serum VEGF level of ESCC patients who only received radiotherapy. The expression of VEGF in ESCC cells after siRNA treatment was verified by Western blot. The sensitivity of ESCC cells to radiation after knocking down VEGF was analyzed by Clonogenic assay and Cell counting kit (CCK-8). The results showed that the level of serum VEGF in patients with ESCC before and after radiotherapy was related to the clinical response, and it was confirmed that knocking down the expression of VEGF in ESCC cells improved the sensitivity to radiation.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Anti-angiogenesis; Curative effect; Esophageal carcinoma; Radiotherapy; Vascular endothelial growth factor

Year:  2022        PMID: 35767192     DOI: 10.1007/s00432-022-04122-x

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

Review 1.  Antiangiogenic therapy: Markers of response, "normalization" and resistance.

Authors:  Karima El Alaoui-Lasmaili; Béatrice Faivre
Journal:  Crit Rev Oncol Hematol       Date:  2018-06-12       Impact factor: 6.312

Review 2.  Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers.

Authors:  Amy M Buckley; Niamh Lynam-Lennon; Hazel O'Neill; Jacintha O'Sullivan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-01-31       Impact factor: 46.802

Review 3.  The effect of anti-angiogenic drugs on regulatory T cells in the tumor microenvironment.

Authors:  Chenxi Hu; Xiaodong Jiang
Journal:  Biomed Pharmacother       Date:  2017-01-16       Impact factor: 6.529

4.  Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells.

Authors:  Hui Gao; Jianxin Xue; Lin Zhou; Jie Lan; Jiazhuo He; Feifei Na; Lifei Yang; Lei Deng; You Lu
Journal:  Cancer Lett       Date:  2015-05-13       Impact factor: 8.679

5.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

6.  Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer.

Authors:  Yongshun Chen; Xiaohong Li; Leiming Guo; Xiaoyuan Wu; Chunyu He; Song Zhang; Yanjing Xiao; Yuanyuan Yang; Daxuan Hao
Journal:  Mol Med Rep       Date:  2015-04-16       Impact factor: 2.952

7.  Intensity-modulated radiotherapy combined with endostar has similar efficacy but weaker acute adverse reactions than IMRT combined with chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma.

Authors:  Min Kang; Fangfang Wang; Xueyin Liao; Pingting Zhou; Rensheng Wang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 8.  Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors.

Authors:  Donelle Cummings; Joyce Wong; Russell Palm; Sarah Hoffe; Khaldoun Almhanna; Shivakumar Vignesh
Journal:  Cancers (Basel)       Date:  2021-02-02       Impact factor: 6.639

9.  VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of mTOR pathway.

Authors:  Li Chen; Guoxiang Lin; Kaihua Chen; Fangzhu Wan; Renba Liang; Yongchu Sun; Xishan Chen; Xiaodong Zhu
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

10.  The Safety and Efficacy of Apatinib Treatment in Addition to Concurrent Chemoradiotherapy in Patients with Nonoperative Locally Advanced Esophageal Squamous Cell Carcinoma.

Authors:  Lijun Hu; Ze Kong; Qinghong Meng; Jianlin Wang; Mengyun Zhou; Jingping Yu; Xiaodong Jiang
Journal:  Med Sci Monit       Date:  2020-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.